Detractors said the study results proved that RDN ... payment for the Medtronic Symplicity Spyral renal denervation (RDN) catheter under the Medicare Hospital Outpatient Prospective Payment ...
Medpage Today on MSN16d
Medicare for Renal Denervation; Cardiac Telemetry App Recall; Stroke Flags in EyesThe Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation for patients with hypertension, Medtronic announced. The FDA said Philips ...
People often take medications for hypertension, but they can stop working over time, said Jason Fontana, Medtronic vice president and general manager of renal denervation. Patients might stop ...
Data from the phase 2 KARDIA-2 study were presented at the American ... the FDA approved the Symplicity radiofrequency renal denervation system (Medtronic). Read Healio’s coverage of this ...
The Associated Press on MSN7d
Keeping blood pressure under control is critical. There’s a new option for tough casesAbout half of U.S. adults have high blood pressure, a major risk for heart attacks, strokes, kidney failure, even dementia.
Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...
This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to the Symplicity™ Spyral renal denervation (RDN) system ...
This surge in market optimism follows the CMS' recent move to initiate a national coverage analysis (NCA) on renal denervation. A favorable final decision could pave the way for Medtronic’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback